SEC Form DFiling only, no announcement found
Swift Cardiovascular, based in Durham, NC, reported $810,000 sold in a private offering of Simple Agreement for Future Equity, with the first sale on January 21, 2026, in a Form D filed with the SEC on September 24, 2026. The filing says 7 investors have already invested. The offering authorizes up to $1,500,000.
Legal name on the filing: Swift Cardiovascular, Inc..
| Amount sold | $810,000Basis: Form D total amount sold, as of the filing of September 24, 2026. Not the announced round size. |
|---|---|
| Total offering | $1,500,000The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $690,000 |
| Securities offered | Other (Simple Agreement for Future Equity) |
| Exemption claimed | Rule 506(b) |
| Date of first sale | January 21, 2026 |
| Investors already invested | 7 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Biotechnology |
| Principal place of business | Durham, NC |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | 2025 |
| Revenue range | Decline to Disclose |
| SEC CIK | 2117135 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Jeffrey Harold Lawson | Executive Officer, Director | None linked |
| Kemal Vincent Schankereli | Director | None linked |
| Howard Vincent Kelly | Director | None linked |
| Richard Francis Murphy | Executive Officer | None linked |
| Jospeh Blakely Long | Executive Officer | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Sep 24, 2026 | D (original) | $810,000 | $1,500,000 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Swift Cardiovascular: SEC Form D deal record", https://vcbeast.com/deals/swift-cardiovascular-form-d-2026-01-21. Source: SEC EDGAR, accession 0002117135-26-000001.